ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market
We wish to extend a huge congratulations to our sponsor ALung Technologies! Just last week, it was announced that ALung has received IDE approval to conduct a VENT-AVOID trial of the Hemolung RAS for the US Market. The device, which achieved its CE mark in 2013, permitting sales throughout the EU, is the world’s first…